References analysis of the Wikipedia article "Melatonina" in the Galician version

ahrq.gov

Buscemi, N. et al. (2004). "Melatonin for Treatment of Sleep Disorders. Summary, Evidence Report/Technology Assessment: Number 108" (Review). U.S. Department of Health & Human Services, Agency for Healthcare Research and Quality. http://www.ahrq.gov/clinic/epcsums/melatsum.htm Arquivado 26 de febreiro de 2012 en Wayback Machine.. Retrieved 2010-05-25.

doi.org

dx.doi.org

Caniato R, Filippini R, Piovan A, Puricelli L, Borsarini A, Cappelletti EM (2003). "Melatonin in plants". Adv. Exp. Med. Biol. Advances in Experimental Medicine and Biology 527: 593–7. ISBN 978-0-306-47755-3. PMID 15206778. doi:10.1007/978-1-4615-0135-0_68.

Paredes SD, Korkmaz A, Manchester LC, Tan DX, Reiter RJ (2009). "Phytomelatonin: a review". J. Exp. Bot. 60 (1): 57–69. PMID 19033551. doi:10.1093/jxb/ern284.

Altun A, Ugur-Altun B (2007). "Melatonin: therapeutic and clinical utilization". Int. J. Clin. Pract. 61 (5): 835–45. PMID 17298593. doi:10.1111/j.1742-1241.2006.01191.x.

Boutin JA, Audinot V, Ferry G, Delagrange P (2005). "Molecular tools to study melatonin pathways and actions". Trends Pharmacol. Sci. 26 (8): 412–9. PMID 15992934. doi:10.1016/j.tips.2005.06.006.

Hardeland R (2005). "Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance". Endocrine 27 (2): 119–30. PMID 16217125. doi:10.1385/ENDO:27:2:119.

Reiter RJ, Acuña-Castroviejo D, Tan DX, Burkhardt S (2001). "Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system". Ann. N. Y. Acad. Sci. 939: 200–15. PMID 11462772. doi:10.1111/j.1749-6632.2001.tb03627.x.

Challet, E. (2007). "Minireview: Entrainment of the Suprachiasmatic Clockwork in Diurnal and Nocturnal Mammals". Endocrinology 148 (12): 5648–55. PMID 17901231. doi:10.1210/en.2007-0804.

Maestroni GJ (2001). "The immunotherapeutic potential of melatonin". Expert Opin Investig Drugs 10 (3): 467–76. PMID 11227046. doi:10.1517/13543784.10.3.467.

Conti A, Conconi S, Hertens E, Skwarlo-Sonta K, Markowska M, Maestroni JM (2000). "Evidence for melatonin synthesis in mouse and human bone marrow cells". J. Pineal Res. 28 (4): 193–202. PMID 10831154. doi:10.1034/j.1600-079X.2000.280401.x.

Burkhardt, Susanne; Tan, Dun Xian; Manchester, Lucien C.; Hardeland, RüDiger; Reiter, Russel J. (2001). "Detection and Quantification of the Antioxidant Melatonin in Montmorency and Balaton Tart Cherries (Prunus cerasus)". Journal of Agricultural and Food Chemistry 49 (10): 4898–902. PMID 11600041. doi:10.1021/jf010321.

Tan, Dun-Xian; Hardeland, RüDiger; Manchester, Lucien C.; Paredes, Sergio D.; Korkmaz, Ahmet; Sainz, Rosa M.; Mayo, Juan C.; Fuentes-Broto, Lorena; Reiter, Russel J. (2009). "The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness". Biological Reviews: 607–23. doi:10.1111/j.1469-185X.2009.00118.x.

Lincoln, G.; Andersson, H; Loudon, A (2003). "Clock genes in calendar cells as the basis of annual timekeeping in mammals--a unifying hypothesis". Journal of Endocrinology 179 (1): 1–13. PMID 14529560. doi:10.1677/joe.0.1790001.

Arendt, Josephine; Skene, Debra Jean (2005). "Melatonin as a chronobiotic". Sleep Medicine Reviews 9 (1): 25–39. PMID 15649736. doi:10.1016/j.smrv.2004.05.002. A melatonina exóxena ten efectos agudos indutores do sono e redutores da temperatura durante o 'tempo diúrno biolóxico', e cando se mide adecuadamente (é máis efectivo ao anoitecer e mencer) cambia a fase do reloxo circadiano humano (sono, melatonina endóxena, temperatura corporal basal, cortisol) a unha fase máis temperá (avance de fase) ou máis serodia (atraso de fase).

Chaturvedi, CM (1984). "Effect of Melatonin on the Adrenl and Gonad of the Common Mynah Acridtheres tristis". Australian Journal of Zoology 32 (6): 803–9. doi:10.1071/ZO9840803.

Chen, H.J. (1981). "Spontaneous and Melatonin-Induced Testicular Regression in Male Golden Hamsters: Augmented Sensitivity of the Old Male to Melatonin Inhibition". Neuroendocrinology 33 (1): 43–6. PMID 7254478. doi:10.1159/000123198.

Kaur C, Ling EA (2008). "Antioxidants and neuroprotection in the adult and developing central nervous system". Curr. Med. Chem. 15 (29): 3068–80. PMID 19075654. doi:10.2174/092986708786848640.

Nayak, S. Kumar; Jegla, T.; Panda, S. (2006). "Role of a novel photopigment, melanopsin, in behavioral adaptation to light". Cellular and Molecular Life Sciences 64 (2): 144–54. PMID 17160354. doi:10.1007/s00018-006-5581-1.

Roberts, Joan E. (2005). "Update on the Positive Effects of Light in Humans". Photochemistry and Photobiology: 490–2. doi:10.1562/2004-12-02-IR-391.

Perreau-Lenz, StéPhanie; Pévet, Paul; Buijs, Ruud M.; Kalsbeek, Andries (2004). "The Biological Clock: The Bodyguard of Temporal Homeostasis". Chronobiology International 21 (1): 1–25. PMID 15129821. doi:10.1081/CBI-120027984.

Ardura, Julio; Gutierrez, Regina; Andres, Jesus; Agapito, Teresa (2003). "Emergence and Evolution of the Circadian Rhythm of Melatonin in Children". Hormone Research 59 (2): 66–72. PMID 12589109. doi:10.1159/000068571.

Sack, RL; Lewy, AJ; Erb, DL; Vollmer, WM; Singer, CM (1986). "Human melatonin production decreases with age". Journal of pineal research 3 (4): 379–88. PMID 3783419. doi:10.1111/j.1600-079X.1986.tb00760.x.

Kayumov, L. (2005). "Blocking Low-Wavelength Light Prevents Nocturnal Melatonin Suppression with No Adverse Effect on Performance during Simulated Shift Work". Journal of Clinical Endocrinology & Metabolism 90 (5): 2755–61. doi:10.1210/jc.2004-2062.

Tan, Dun-Xian; Manchester, Lucien C.; Terron, Maria P.; Flores, Luis J.; Reiter, Russel J. (2007). "One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species?". Journal of Pineal Research 42 (1): 28–42. PMID 17198536. doi:10.1111/j.1600-079X.2006.00407.x.

Reiter RJ, Manchester LC, Tan DX (2010). "Neurotoxins: free radical mechanisms and melatonin protection". Curr Neuropharmacol 8 (3): 194–210. PMC 3001213. PMID 21358970. doi:10.2174/157015910792246236.

Poeggeler, Burkhard; Saarela, Seppo; Reiter, Russel J.; Tan, DUN-Xian; Chen, LI-DUN; Manchester, Lucien C.; Barlow-Walden, Lornell R. (2006). "Melatonin-A Highly Potent Endogenous Radical Scavenger and Electron Donor: New Aspects of the Oxidation Chemistry of this Indole Accessed in vitroa". Annals of the New York Academy of Sciences 738: 419–20. PMID 7832450. doi:10.1111/j.1749-6632.1994.tb21831.x.

Tan, Dun-Xian; Manchester, Lucien C.; Reiter, Russel J.; Qi, Wen-Bo; Karbownik, Malgorzata; Calvo, Juan R. (2000). "Significance of Melatonin in Antioxidative Defense System: Reactions and Products". Neurosignals 9 (3–4): 137–59. PMID 10899700. doi:10.1159/000014635.

Karbownik, M; Reiter, Russel J.; Cabrera, Javier; Garcia, Joaquin J. (2001). "Comparison of the protective effect of melatonin with other antioxidants in the hamster kidney model of estradiol-induced DNA damage". Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 474: 87–92. doi:10.1016/S0027-5107(00)00164-0.

Tutunculer, Filiz; Eskiocak, Sevgi; Basaran, Umit Nusret; Ekuklu, Galip; Ayvaz, Suleyman; Vatansever, Ulfet (2005). "The protective role of melatonin in experimental hypoxic brain damage". Pediatrics International 47 (4): 434–9. PMID 16091083. doi:10.1111/j.1442-200x.2005.02085.x.

Anisimov, V; Alimova, IN; Baturin, DA; Popovich, IG; Zabezhinski, MA; Rosenfeld, SV; Manton, KG; Semenchenko, AV; Yashin, AI (2003). "Dose-dependent effect of melatonin on life span and spontaneous tumor incidence in female SHR mice". Experimental Gerontology 38 (4): 449–61. PMID 12670632. doi:10.1016/S0531-5565(02)00240-1.

Oaknin-Bendahan, Sol; Anis, Yossi; Nir, Isaac; Zisapel, Nava (1995). "Effects of long-term administration of melatonin and a putative antagonist on the ageing rat". NeuroReport 6 (5): 785–8. PMID 7605949. doi:10.1097/00001756-199503270-00020.

Carrillo-Vico, Antonio; Guerrero, Juan M.; Lardone, Patricia J.; Reiter, Russel J. (2005). "A review of the multiple actions of melatonin on the immune system". Endocrine 27 (2): 189–200. PMID 16217132. doi:10.1385/ENDO:27:2:189.

Carrillo-Vico, A. (2004). "Human lymphocyte-synthesized melatonin is involved in the regulation of the interleukin-2/interleukin-2 receptor system". Journal of Clinical Endocrinology & Metabolism 90 (2): 992–1000. doi:10.1210/jc.2004-1429.

Cutolo, M; Maestroni, GJ (2005). "The melatonin-cytokine connection in rheumatoid arthritis". Annals of the Rheumatic Diseases 64 (8): 1109–11. PMC 1755599. PMID 16014678. doi:10.1136/ard.2005.038588.

Melke, J; Goubran Botros, H; Chaste, P; Betancur, C; Nygren, G; Anckarsäter, H; Rastam, M; Ståhlberg, O; Gillberg, I C (2007). "Abnormal melatonin synthesis in autism spectrum disorders". Molecular Psychiatry 13 (1): 90–8. PMC 2199264. PMID 17505466. doi:10.1038/sj.mp.4002016.

Wright, Barry; Sims, David; Smart, Siobhan; Alwazeer, Ahmed; Alderson-Day, Ben; Allgar, Victoria; Whitton, Clare; Tomlinson, Heather; Bennett, Sophie (2010). "Melatonin Versus Placebo in Children with Autism Spectrum Conditions and Severe Sleep Problems Not Amenable to Behaviour Management Strategies: A Randomised Controlled Crossover Trial". Journal of Autism and Developmental Disorders 41 (2): 175–84. PMID 20535539. doi:10.1007/s10803-010-1036-5.

Sharman, Edward H.; Sharman, Kaizhi G.; Ge, Yuan-Wen; Lahiri, Debomoy K.; Bondy, Stephen C. (2004). "Age-related changes in murine CNS mRNA gene expression are modulated by dietary melatonin". Journal of Pineal Research 36 (3): 165–70. PMID 15009506. doi:10.1046/j.1600-079X.2003.00112.x.

Acuna-Castroviejo, Dario; Martin, Miguel; MacIas, Manuel; Escames, Germaine; Leon, Josefa; Khaldy, Huda; Reiter, Russel J. (2001). "Melatonin, mitochondria, and cellular bioenergetics". Journal of Pineal Research 30 (2): 65–74. PMID 11270481. doi:10.1034/j.1600-079X.2001.300201.x. Resumo divulgativo – Science Daily (April 24, 2007).

Srinivasan, V.; Pandi-Perumal, SR.; Trahkt, I.; Spence, DW.; Poeggeler, B.; Hardeland, R.; Cardinali, DP. (2009). "Melatonin and melatonergic drugs on sleep: possible mechanisms of action.". Int J Neurosci 119 (6): 821–46. PMID 19326288. doi:10.1080/00207450802328607.

Fornaro, M.; Prestia, D.; Colicchio, S.; Perugi, G. (2010). "A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.". Curr Neuropharmacol 8 (3): 287–304. PMID 21358978. doi:10.2174/157015910792246227.

Turek, F; Gillette, M (2004). "Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists". Sleep Medicine 5 (6): 523–32. PMID 15511698. doi:10.1016/j.sleep.2004.07.009.

Wade, Alan G; Ford, Ian; Crawford, Gordon; McMahon, Alex D; Nir, Tali; Laudon, Moshe; Zisapel, Nava (2007). "Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes". Current Medical Research and Opinion 23 (10): 2597–605. PMID 17875243. doi:10.1185/030079907X233098.

Buscemi, N.; Vandermeer, B; Hooton, N; Pandya, R; Tjosvold, L; Hartling, L; Vohra, S; Klassen, TP; Baker, G (2006). "Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis". BMJ 332 (7538): 385–93. PMC 1370968. PMID 16473858. doi:10.1136/bmj.38731.532766.F6.

Buscemi, Nina; Vandermeer, Ben; Hooton, Nicola; Pandya, Rena; Tjosvold, Lisa; Hartling, Lisa; Baker, Glen; Klassen, Terry P.; Vohra, Sunita (2005). "The Efficacy and Safety of Exogenous Melatonin for Primary Sleep Disorders. A Meta-Analysis". Journal of General Internal Medicine 20 (12): 1151–8. PMC 1490287. PMID 16423108. doi:10.1111/j.1525-1497.2005.0243.x.

Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Baker G, Klassen TP, Vohra S (2005). "The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis". J Gen Intern Med 20 (12): 1151–8. PMC 1490287. PMID 16423108. doi:10.1111/j.1525-1497.2005.0243.x.

Sack RL, Brandes RW, Kendall AR, Lewy AJ (2000). "Entrainment of free-running circadian rhythms by melatonin in blind people". N. Engl. J. Med. 343 (15): 1070–7. PMID 11027741. doi:10.1056/NEJM200010123431503.

Terry PD, Villinger F, Bubenik GA, Sitaraman SV (2009). "Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research". Inflamm. Bowel Dis. 15 (1): 134–40. PMID 18626968. doi:10.1002/ibd.20527.

Filadelfi, Ana Maria Caliman; Castrucci, Ana Maria de Lauro (1996). "Comparative aspects of the pineal/melatonin system of poikilothermic vertebrates". Journal of Pineal Research 20 (4): 175–86. PMID 8836950. doi:10.1111/j.1600-079X.1996.tb00256.x.

Sugden, David; Davidson, Kathryn; Hough, Kate A.; Teh, Muy-Teck (2004). "Melatonin, Melatonin Receptors and Melanophores: A Moving Story". Pigment Cell Research 17 (5): 454–60. PMID 15357831. doi:10.1111/j.1600-0749.2004.00185.x.

Lynch, H.; Wurtman, R.; Moskowitz, M.; Archer, M.; Ho, M. (1975). "Daily rhythm in human urinary melatonin". Science 187 (4172): 169–71. PMID 1167425. doi:10.1126/science.1167425.

Arendt, J. (2005). "Melatonin: Characteristics, Concerns, and Prospects". Journal of Biological Rhythms 20 (4): 291–303. PMID 16077149. doi:10.1177/0748730405277492. Hai poucas evidencias de toxicidade a curto prazo ou de efectos indesexados en humanos. A extraordinaria publicidade dos milagreiros poderes da melatonina do recente pasado prexudicou á aceptación dos seus verdadeiros beneficios.

Arendt, Josephine (2000). "Melatonin, Circadian Rhythms, and Sleep". New England Journal of Medicine 343 (15): 1114–6. PMID 11027748. doi:10.1056/NEJM200010123431510.

nih.gov

ncbi.nlm.nih.gov

Paredes SD, Korkmaz A, Manchester LC, Tan DX, Reiter RJ (2009). "Phytomelatonin: a review". J. Exp. Bot. 60 (1): 57–69. PMID 19033551. doi:10.1093/jxb/ern284.

Altun A, Ugur-Altun B (2007). "Melatonin: therapeutic and clinical utilization". Int. J. Clin. Pract. 61 (5): 835–45. PMID 17298593. doi:10.1111/j.1742-1241.2006.01191.x.

Boutin JA, Audinot V, Ferry G, Delagrange P (2005). "Molecular tools to study melatonin pathways and actions". Trends Pharmacol. Sci. 26 (8): 412–9. PMID 15992934. doi:10.1016/j.tips.2005.06.006.

Challet, E. (2007). "Minireview: Entrainment of the Suprachiasmatic Clockwork in Diurnal and Nocturnal Mammals". Endocrinology 148 (12): 5648–55. PMID 17901231. doi:10.1210/en.2007-0804.

Maestroni GJ (2001). "The immunotherapeutic potential of melatonin". Expert Opin Investig Drugs 10 (3): 467–76. PMID 11227046. doi:10.1517/13543784.10.3.467.

Hattori A, Migitaka H, Iigo M, Itoh M, Yamamoto K, Ohtani-Kaneko R, Hara M, Suzuki T, Reiter RJ (1995). "Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates". Biochem. Mol. Biol. Int. 35 (3): 627–34. PMID 7773197.

Kaur C, Ling EA (2008). "Antioxidants and neuroprotection in the adult and developing central nervous system". Curr. Med. Chem. 15 (29): 3068–80. PMID 19075654. doi:10.2174/092986708786848640.

Richardson, GS (2005). "The human circadian system in normal and disordered sleep". The Journal of clinical psychiatry. 66 Suppl 9: 3–9; quiz 42–3. PMID 16336035.

Brainard, GC; Hanifin, JP; Greeson, JM; Byrne, B; Glickman, G; Gerner, E; Rollag, MD (2001). "Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor". The Journal of neuroscience : the official journal of the Society for Neuroscience 21 (16): 6405–12. PMID 11487664.

Arushanian, EB; Beĭer, EV (2002). "Immunotropic properties of pineal melatonin". Eksperimental'naia i klinicheskaia farmakologiia 65 (5): 73–80. PMID 12596522.

Carrillo-Vico, A; Reiter, RJ; Lardone, PJ; Herrera, JL; Fernández-Montesinos, R; Guerrero, JM; Pozo, D (2006 May). "The modulatory role of melatonin on immune responsiveness". Current opinion in investigational drugs 7 (5): 423–31. PMID 16729718.

Maestroni, GJ (1999). "Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer". Adv Exp Med Biol. 467: 217–26. ISSN 0065-2598. PMID 10721059.

Mills E, Wu P, Seely D, Guyatt G (November 2005). "Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis". J. Pineal Res. 39 (4): 360–6. doi:10.1111/j.1600-079X.2005.00258.x. PMID 16207291.

Pappolla MA, Sos M, Omar RA, Bick RJ, Hickson-Bick DL, Reiter RJ, Efthimiopoulos S, Robakis NK (March 1997). "Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide". J. Neurosci. 17 (5): 1683–90. PMID 9030627.

Bellipanni G, DI Marzo F, Blasi F, Di Marzo A (December 2005). "Effects of melatonin in perimenopausal and menopausal women: our personal experience". Ann. N. Y. Acad. Sci. 1057: 393–402. doi:10.1196/annals.1356.030. PMID 16399909.

Morera, AL; Henry, M; De La Varga, M (2001). "Safety in melatonin use". Actas espanolas de psiquiatria 29 (5): 334–7. PMID 11602091.

Lerner, AB; Case, JD; Takahashi, Y (1960). "Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands". The Journal of biological chemistry 235: 1992–7. PMID 14415935.

Lynch, H.; Wurtman, R.; Moskowitz, M.; Archer, M.; Ho, M. (1975). "Daily rhythm in human urinary melatonin". Science 187 (4172): 169–71. PMID 1167425. doi:10.1126/science.1167425.

Arendt, Josephine (2000). "Melatonin, Circadian Rhythms, and Sleep". New England Journal of Medicine 343 (15): 1114–6. PMID 11027748. doi:10.1056/NEJM200010123431510.

pubchem.ncbi.nlm.nih.gov

PubChem compound Melatonin

nimh.nih.gov

psu.edu

hmc.psu.edu

"Study Shows Melatonin Supplements May Make Standing A Hazard For The Cardiovascular-Challenged" (DOC) (Press release). Penn State College of Medicine, Milton S. Hershey Medical Center. September 2003. http://www.hmc.psu.edu/news/pr/2003/sept/Ray_melatonin.doc Arquivado 17 de decembro de 2008 en Wayback Machine.. Retrieved 2006-07-21. (MS Word Format) [1] Arquivado 17 de decembro de 2008 en Wayback Machine.

sciencedaily.com

web.archive.org

ChemSpider Melatonin Arquivado 21 de xaneiro de 2012 en Wayback Machine.

Ratzburg, Courtney (Undated). "Melatonin: The Myths and Facts". Vanderbilt University. Arquivado dende o orixinal o 12 de decembro de 2007. Consultado o 2007-12-02.

Methods of inducing sleep using melatonin: US Patent # 5449683 Arquivado 04 de febreiro de 2018 en Wayback Machine. retrieved 8 January 2012

Melatonina (Galician Wikipedia)

ahrq.gov

archive.org

books.google.com

chemspider.com

csiro.au

publish.csiro.au

doi.org

dx.doi.org

drugs.com

kidshealth.org

mayoclinic.com

nih.gov

ncbi.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

nimh.nih.gov

patentgenius.com

psu.edu

hmc.psu.edu

sciencedaily.com

sleepdex.org

umm.edu

vanderbilt.edu

web.archive.org

worldcat.org